Researchers will identify DNA mutations associated with the predisposition for hepatitis in Doberman pinschers, as well as search for biomarkers in the blood predictive of early-stage disease to help improve earlier intervention, disease monitoring and treatment success.
Researchers are studying the feasibility of an adjunct immunotherapy for large- and giant-breed dogs with osteosarcoma that are not good candidates for cancer surgery or limb amputation.
Researchers will study the aging process, including genetically programmed aging “clocks” and anti-aging strategies, in a well-studied population of retired sled dogs.
Researchers will study if toxic heavy metals are associated with increased risk of health challenges in aging dogs, including cognitive decline, hearing loss and visual decline.